For life sciences companies preparing for potential acquisition or investment, intellectual property (IP) often represents the cornerstone of your value, making thorough preparation and strategic foresight essential for...more
4/30/2025
/ Acquisitions ,
Artificial Intelligence ,
Due Diligence ,
Intellectual Property Protection ,
Investors ,
IP License ,
Life Sciences ,
Mergers ,
Patents ,
Pharmaceutical Patents ,
Strategic Planning
Walking away from Digital Health Counsel 2024 AI Summit, the stunning impact that AI and data-powered innovation are making on healthcare is undeniable. Organized by Ogden Murphy Wallace and sponsored by Fenwick, the summit...more